Cadpride MP 1mg/500mg/15mg Tablet SR
Marketer
Caddes Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cadpride MP 1mg/500mg/15mg Tablet SR
Metformin/Pioglitazone/Voglibose extended-release tablets (1mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this combination therapy enhances insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions; take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia risk increases with concurrent antidiabetic medications, alcohol consumption, or missed meals; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Uses of Cadpride MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Cadpride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Cadpride MP 1mg/500mg/15mg Sustained-Release tablets should be taken with meals.
Common Side effects of Cadpride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cadpride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. The Cadpride MP 1mg/500mg/15mg Extended-Release tablet should be taken with a meal.
How Cadpride MP 1mg/500mg/15mg Tablet SR works:
Cadpride MP 1mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Cadpride MP 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Cadpride MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Cadpride MP 1mg/500mg/15mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Cadpride MP 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Cadpride MP 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cadpride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Cadpride MP 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Cadpride MP 1mg/500mg/15mg Tablet SR :
Should you forget a Cadpride MP 1mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cadpride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently